Transarterial infusion chemotherapy and embolization (TAICE) as a pre-operative therapy for patients with locally advanced gastric cancer (LAGC): A prospective, single-arm, pilot study.

被引：0
|
作者：
Min, Lingqiang
Zhou, Bo
Zhou, Peng
Luo, Rongkui
Ding, Yuqin
Cui, Yuehong
Shi, Zhongyi
Gu, Yuan
Sun, Yihong
Wang, Xuefei
Tang, Zhaoqing
机构：
[1] Fudan Univ, Dept Gastrointestinal Surg, Zhongshan Hosp, Shanghai, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Dept Emergency Surg, Shanghai, Peoples R China
[3] Fudan Univ, Zhongshan Hosp, Dept Intervent Radiol, Shanghai, Peoples R China
[4] Fudan Univ, Zhongshan Hosp, Dept Gastrointestinal Surg, Shanghai, Peoples R China
[5] Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai, Peoples R China
[6] Fudan Univ, Zhongshan Hosp, Dept Radiol, Shanghai, Peoples R China
[7] Fudan Univ, Zhongshan Hosp, Dept Med Oncol, Shanghai, Peoples R China
[8] Fudan Univ, Zhongshan Hosp, Zhongshan Hosp, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 4_SUPPL期
基金：
上海市自然科学基金;
关键词：
D O I：
10.1200/JCO.2025.43.4_suppl.436
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：436 / 436
页数：1
相关论文
共 50 条
  • [41] Apatinib combined with paclitaxel-based chemotherapy in patients with taxane-resistant advanced gastric cancer: a single-arm exploratory study
    Zhao, Shen
    Fan, Nanfeng
    Li, Hui
    Liu, Jie
    Huang, Feng
    Chen, Yigui
    Zhou, Min
    Yu, Jiaqing
    Lin, Rongbo
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (19)
  • [42] Camrelizumab combined with SOX regimen in the first-line treatment of unresectable advanced or recurrent gastric cancer: A single-arm, prospective, open clinical study.
    Han, Zhengxiang
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [43] Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial)
    Ding, Chengzhi
    Guo, Yijun
    Zhou, Yaning
    He, Yi
    Chen, Chunji
    Zhang, Ming
    Guo, Xufeng
    BMC CANCER, 2023, 23 (01)
  • [44] Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial)
    Chengzhi Ding
    Yijun Guo
    Yaning zhou
    Yi He
    Chunji Chen
    Ming Zhang
    Xufeng Guo
    BMC Cancer, 23
  • [45] Donafenib combined with camrelizumab and transarterial chemoembolization (TACE) as conversion therapy for unresectable hepatocellular carcinoma (uHCC): A prospective, single-arm, phase II study.
    Cao, Yajuan
    Zhang, Xuebin
    Yue, Yang
    Peng, Jin
    Li, Binghua
    Shi, Jiong
    Tang, Min
    Chen, Chaobo
    Su, Ke
    Zhang, Laizhu
    Cheng, Chunxiao
    Yu, Decai
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [46] Cambrelizumab plus chemotherapy as conversion therapy for unresectable metastatic gastric cancer: A single-arm, multicenter, prospective clinical trial.
    Li, Shuang
    He, Liang
    Li, Meng
    Wang, Quan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16032 - E16032
  • [47] Combination of modified FOLFIRINOX with stereotactic body radiotherapy as an induction therapy for locally advanced pancreatic adenocarcinoma - a prospective single-arm study
    Piatek, Micha
    Bienkowski, Micha
    Kusnierz, Katarzyna
    Pilch-Kowalczyk, Joanna
    Imielska-Zdunek, Dorota
    Mrowiec, Sawomir
    Lampe, Pawe
    Radecka, Barbara
    Nawrocki, Sergiusz
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2024, 28 (01): : 15 - 30
  • [48] Efficacy and safety of second-line therapy with apatinib combined with chemotherapy as second-line therapy in advanced gastric cancer: a single-arm, open-label, prospective, multicenter study
    Zhang, Yan
    Xu, Junying
    Wang, Qiong
    Ling, Guohong
    Mao, Yong
    Cai, Maohuai
    Yang, Yang
    Mei, Jingfeng
    Han, Zhengxiang
    Feng, Jifeng
    Wu, Yuan
    Shi, Lin
    Wen, Shaodi
    Shen, Bo
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (11)
  • [49] Pre-operative assessment of residual disease in locally advanced breast cancer patients: A sequential study by quantitative diffusion weighted MRI as a function of therapy
    Agarwal, Khushbu
    Sharma, Uma
    Sah, Rani G.
    Mathur, Sandeep
    Hari, Smriti
    Seenu, Vurthaluru
    Parshad, Rajinder
    Jagannathan, Naranamangalam R.
    MAGNETIC RESONANCE IMAGING, 2017, 42 : 88 - 94
  • [50] Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): a multicentre, single-arm, phase 2 trial
    Li, Kezhen
    Chen, Jing
    Hu, Yingjie
    Wang, Yan-Zhou
    Shen, Yuanming
    Chen, Gang
    Peng, Wenju
    Fang, Zixuan
    Xia, Bairong
    Chen, Xiaojun
    Song, Kun
    Wang, Yingmei
    Zou, Dongling
    Wang, Yan-Chun
    Han, Yingyan
    Feng, Xue
    Yuan, Jing
    Guo, Shuaiqingying
    Meng, Xiaolin
    Feng, Chenzhao
    Chen, Yin
    Yang, Jie
    Fan, Junpeng
    Wang, Jianliu
    Ai, Jihui
    Ma, Ding
    Sun, Chaoyang
    LANCET ONCOLOGY, 2024, 25 (01): : 76 - 85
12345